Insider Transactions in Q1 2022 at Zymeworks Inc. (ZYME)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2022
|
Neil Josephson Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,395
+11.7%
|
-
|
|
Mar 10
2022
|
Neil A Klompas Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,979
-18.33%
|
$17,874
$6.88 P/Share
|
|
Mar 10
2022
|
Neil A Klompas Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,208
+14.93%
|
-
|
|
Jan 07
2022
|
Neil Josephson Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+31.02%
|
$70,000
$14.28 P/Share
|
|
Jan 07
2022
|
Neil A Klompas Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
277
+2.45%
|
$3,601
$13.94 P/Share
|
|
Jan 07
2022
|
Anthony J. Polverino Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74
+0.2%
|
$962
$13.94 P/Share
|
|
Jan 07
2022
|
Neil Josephson Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65
+2.98%
|
$845
$13.94 P/Share
|